DAXOR CORP (DXR) director receives 2,500 stock options at $10.14 strike

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

DAXOR CORP director Edward Feuer received a grant of 2,500 stock options as compensation. These options give him the right to buy common stock at an exercise price of $10.14 per share and expire on June 23, 2031.

The grant is contingent on approval by the Securities & Exchange Commission to amend the Daxor Corporation 2020 Incentive Compensation Plan. The options are scheduled to vest in three annual installments: 833 options on June 23, 2026, 833 on June 23, 2027, and 834 on June 23, 2028. After this grant, Feuer holds 2,500 stock options directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Feuer Edward

Role null

Type	Security	Shares	Price	Value
Grant/Award	Stock Options (right to buy)	2,500	$0.00	--

Holdings After Transaction: Stock Options (right to buy) — 2,500 shares (Direct, null)

Footnotes (1)

Stock options granted on June 23, 2026 are contingent on the approval of the Securities & Exchange Commission ("SEC") to amend the Daxor Corporation 2020 Incentive Compensation Plan (the "Plan"). The stock options will vest in three installments on June 23, 2026 (833), June 23, 2027 (883) and June 23, 2028 (834)

Key Figures

Options granted: 2,500 options Exercise price: $10.14 per share Expiration date: June 23, 2031 +4 more

7 metrics

Options granted 2,500 options Stock option grant to director on June 23, 2026

Exercise price $10.14 per share Stock options strike price

Expiration date June 23, 2031 Option term end for grant

Vesting 2026 833 options First vesting installment on June 23, 2026

Vesting 2027 833 options Second vesting installment on June 23, 2027

Vesting 2028 834 options Final vesting installment on June 23, 2028

Options held after grant 2,500 options Total stock options following transaction

Key Terms

Stock Options (right to buy), exercise price, vesting, 2020 Incentive Compensation Plan, +1 more

5 terms

Stock Options (right to buy) financial

"security_title: Stock Options (right to buy)"

exercise price financial

"conversion_or_exercise_price: 10.1400"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vesting financial

"The stock options will vest in three installments on June 23, 2026 (833), June 23, 2027 (883) and June 23, 2028 (834)"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

2020 Incentive Compensation Plan financial

"to amend the Daxor Corporation 2020 Incentive Compensation Plan (the "Plan")"

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/25/2026 - 05:11 PM Accepted by SEC EDGAR 06/25/2026 - 05:11 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Feuer Edward

(Last)

(First)

(Middle)

C/O FEUER & ORLANDO, LLP

12 WEST 37TH STREET, STE 502

(Street)

NEW YORK,

NEW YORK

10018

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
DAXOR CORP [ DXR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/23/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Options (right to buy)	$10.14	06/23/2026⁽¹⁾		A		2,500		⁽²⁾	06/23/2031	COMMON STOCK	2,500	$0	2,500	D

Explanation of Responses:

1. Stock options granted on June 23, 2026 are contingent on the approval of the Securities & Exchange Commission ("SEC") to amend the Daxor Corporation 2020 Incentive Compensation Plan (the "Plan").

2. The stock options will vest in three installments on June 23, 2026 (833), June 23, 2027 (883) and June 23, 2028 (834)

	/s/ Edward Feuer	06/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did DAXOR CORP (DXR) director Edward Feuer report in this Form 4?

Edward Feuer reported a grant of 2,500 stock options. These options allow him to buy DAXOR CORP common stock at $10.14 per share and represent compensation rather than an open-market purchase or sale.

What is the exercise price and expiration date of Edward Feuer’s DAXOR (DXR) stock options?

The granted stock options have an exercise price of $10.14 per share. They are scheduled to expire on June 23, 2031, giving Feuer a multi-year window to exercise his rights to buy DAXOR CORP common stock.

How do the newly granted DAXOR CORP (DXR) stock options vest for Edward Feuer?

The 2,500 stock options vest in three installments. The schedule is 833 options on June 23, 2026, another 833 on June 23, 2027, and the remaining 834 on June 23, 2028, creating a three-year vesting period.

Are Edward Feuer’s new DAXOR (DXR) stock options already effective?

The options are contingent on SEC approval of an amendment to Daxor’s 2020 Incentive Compensation Plan. This means the grant depends on that regulatory approval before fully taking effect under the stated plan terms.

How many DAXOR CORP (DXR) stock options does Edward Feuer hold after this grant?

After this grant, Feuer is shown holding 2,500 stock options directly. Each option corresponds to one share of DAXOR CORP common stock, subject to vesting conditions and the overall plan amendment approval.